Main > ONCOLOGY (**) > Skin Cancer>Melanoma>Lymph Node(s)> > Adjuvant Treat.: > USA. M. PembrolizuMAb Inj.



USA. M. PembrolizuMAb Inj.'s subsections
(*) CA Approval Date: 2022. 09.13
(*) EU Approval Date : 2018. 12.17.
(*) JP Approval Date: 2019. 01.03.
(*) USA Approval Date: 2019. 02.19.
>Following Complete Resection
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
RTM
RTM Web-Site

USA. M. PembrolizuMAb Inj.'s products
This section has no products